BELLUS HEALTH INT LTD has a total of 37 patent applications. Its first patent ever was published in 1994. It filed its patents most often in EPO (European Patent Office), New Zealand and United States. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and machines are ORPHOMED INC, LEONIDOV NIKOLAI B and TECHFIELDS PHARMA CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 6 | |
#2 | New Zealand | 6 | |
#3 | United States | 6 | |
#4 | Australia | 4 | |
#5 | Israel | 4 | |
#6 | WIPO (World Intellectual Property Organization) | 4 | |
#7 | Canada | 2 | |
#8 | Republic of Korea | 2 | |
#9 | EAPO (Eurasian Patent Organization) | 1 | |
#10 | Mexico | 1 | |
#11 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Machines | |
#4 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Acyclic or carbocyclic compounds | |
#4 | Heterocyclic compounds | |
#5 | Unspecified technologies | |
#6 | Special acyclic compounds | |
#7 | Sugars | |
#8 | Peptides | |
#9 | Steroids | |
#10 | Fermentation |
# | Name | Total Patents |
---|---|---|
#1 | Kong Xianqi | 16 |
#2 | Gervais Francine | 11 |
#3 | Migneault David | 9 |
#4 | Szarek Walter A | 7 |
#5 | Wu Xinfu | 6 |
#6 | Valade Isabelle | 5 |
#7 | Hamet Pavel | 4 |
#8 | Weaver Donald F | 4 |
#9 | Gupta Ajay | 4 |
#10 | Szarek Walter | 4 |
Publication | Filing date | Title |
---|---|---|
WO2010054485A1 | Organic nutrient salts, methods of preparation and uses | |
AU2008207470A1 | Use of amyloid inhibitors for modulating neuronal cell death | |
AU2006228064A1 | Method for modulating macrophage activation | |
AU2006203051A1 | Use of amyloid inhibitors for modulating neuronal cell death | |
AU2005203635A1 | Methods and compounds for inhibiting amyloid deposits | |
NZ544687A | Treatment of amyloid- and epileptogenesis-associated diseases | |
EP1276483A2 | Compositions and methods for treating amyloidosis using sulphonate derivatives | |
NZ568553A | Treatment of inflammation, AB-induced cell toxicity, neuronal cell death or neuronal loss in subjects suffering from AlzheimerÆs disease |